Delivery Order SPE2D018D0006-SPE2D325F4806

Award Date 1/24/25
Potential Completion Date 1/29/25
Potential Value $11K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Westwood, NJ 07677, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Eagle Pharmaceuticals, Inc., a for-profit pharmaceutical manufacturer. The contract, valued at $5,080.62, is for the supply of 250mg vials of the drug Ryanodex, which is used to treat and prevent malignant hyperthermia in high-risk patients. This delivery order contract is not set aside and is part of a larger Federal Supply Schedule (FSS) contract between Eagle...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Eagle Pharmaceuticals, Inc., a for-profit pharmaceutical manufacturer. The contract is for the supply of Ryanodex, a 250mg injectable medication used for treating and preventing malignant hyperthermia in high-risk patients. The contract is a firm fixed-price delivery order with a ceiling value of $5,292.66 and a period of performance through February 10, 2025. Eagle Pharmaceuticals is the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Eagle Pharmaceuticals, Inc., a for-profit pharmaceutical manufacturer. The contract, valued at $170,847.06, is for the delivery of other medical supplies, specifically the 250mg injectable drug Ryanodex used to treat and prevent malignant hyperthermia. The delivery order has a firm fixed-price pricing type and an ultimate completion date of April 7, 2025. This contract is not set aside and...
The U.S. Defense Logistics Agency Troop Support Medical awarded a delivery order contract to Eagle Pharmaceuticals, Inc., a for-profit manufacturer of pharmaceutical products, to provide the drug Ryanodex (250mg vials). The contract has a firm fixed price of $92,838.80 and a period of performance through April 6, 2023. This award is part of Eagle Pharmaceuticals' existing Federal Supply Schedule contract with the Department of Veterans Affairs Veterans Health Administration, which has a...
This federal contract award to Eagle Pharmaceuticals, Inc., a for-profit pharmaceutical manufacturer, is a delivery order from the Defense Logistics Agency Troop Support Medical. The contract is for the supply of 250mg vials of the drug Ryanodex, with a firm fixed price of $1,693.54 and a completion date of January 5, 2024. The place of performance is Westwood, New Jersey. This delivery order is part of a larger Federal Supply Schedule contract held by Eagle Pharmaceuticals through the...
The Defense Logistics Agency Troop Support Medical awarded Eagle Pharmaceuticals, Inc., doing business as Eagle Pharmaceuticals, a $9,748.26 firm fixed price delivery order to supply 250 mg vials of the drug Ryanodex. Performance will take place in Westwood, New Jersey over a period of one week from September 15 through September 20, 2023. The Defense Logistics Agency Troop Support Medical supports the medical readiness of the Department of Defense through the procurement and distribution of...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of Ryanodex 250 mg vials. The delivery order, valued at $4,468.92, has a firm fixed price and an ultimate completion date of April 19, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as a prime contractor to the U.S. Department of Defense, delivering a wide range...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 250 mg Ryanodex vials. The contract has a ceiling value of $4,468.92 and an ultimate completion date of August 14, 2024. It is a delivery order contract with a firm fixed-price pricing type. This award is not set aside for any specific business type. Amerisourcebergen Drug Corp's Corporate Office Division is the...
This federal contract award, valued at $8,996.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RYANODEX 250 MG VIALS, a pharmaceutical product, with a period of performance through March 5, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,623.36 Firm Fixed Price delivery order covers the supply of RYANODEX 250 MG VIALS, a specialty pharmaceutical product. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle...
  • SPE2D018D0006
    Indefinite Delivery Contract
  • SPE2D018D0006-SPE2D325F4806
    Delivery Order

This is a firm fixed-price delivery order contract (SPE2D018D0006|SPE2D325F4806) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Eagle Pharmaceuticals, Inc., a for-profit pharmaceutical manufacturer, for the supply of Ryanodex (250 mg vials), a drug used to treat and prevent malignant hyperthermia. The contract has a ceiling value of $10,585.32 and an ultimate completion date of January 29, 2025. This award is not associated with a set-aside program. Eagle Pharmaceuticals holds a Federal Supply Schedule (FSS) contract with the Department of Veterans Affairs (VA) Veterans Health Administration, valued at $30,890,560 and effective from February 2024 through January 2029, which enables the VA and DLA to efficiently procure the company's pharmaceutical products, including Ryanodex. This contract supports medical readiness initiatives for the Department of Defense by providing critical pharmaceutical supplies.

Generated 4/27/25, 12:52 AM